FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Fernandez Jose Luis 		2. Issuer Name and Ticker or Trading Symbol

IMS Health Holdings, Inc. [ IMS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Senior VP, Global Services
(Last)          (First)          (Middle)

C/O IMS HEALTH HOLDINGS, INC., 83 WOOSTER HEIGHTS ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/2/2016
(Street)

DANBURY, CT 06810
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy)   $7.20   2/2/2016     A      2000       5/8/2016   5/8/2022   Common Stock   2000   $0   18000   (1) D  
 
Option (Right to Buy)   $10.90   2/2/2016     A      4000       5/8/2016   5/8/2023   Common Stock   4000   $0   42000   (2) D  
 
Stock Appreciation Right   $23.00   2/2/2016     A      26581         (3) 2/2/2026   Common Stock   26581   $0   26581   D  
 

Explanation of Responses:
( 1)  On 05/08/2012, the reporting person was granted a performance-based option to purchase 10,000 shares of common stock. This option is eligible to vest in five equal annual installments beginning 05/08/2013, subject to the achievement of certain performance criteria for each of the fiscal years ending December 31, 2012, 2013, 2014, 2015, and 2016. The performance criteria for 2015 were met and their achievement approved on 02/02/2016, resulting in 2,000 options earned.
( 2)  On 05/08/2013, the reporting person was granted a performance-based option to purchase 20,000 shares of common stock. This option is eligible to vest in five equal annual installments beginning 05/08/2014, subject to the achievement of certain performance criteria for each of the fiscal years ending December 31, 2013, 2014, 2015, 2016, and 2017. The performance criteria for 2015 were met and their achievement approved on 02/02/2016, resulting in 4,000 options earned.
( 3)  This stock appreciation right vests in four annual installments beginning on 02/02/2017.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Fernandez Jose Luis
C/O IMS HEALTH HOLDINGS, INC.
83 WOOSTER HEIGHTS ROAD
DANBURY, CT 06810

Senior VP, Global Services

Signatures
/s/ Harvey A. Ashman, Attorney-in-Fact 2/4/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.